Details of the Drug

General Information of Drug (ID: DMYO1IO)

• Drug Name: Pabinafusp alfa

Indication

Disease Entry	ICD 11	Status	REF
Mucopolysaccharidosis II	5C56.31	Phase 2/3	[1]

• Drug Type: Fusion protein
• Cross-matching ID:
  UNII: TRF8S0U6ON
  DrugBank ID: DB15633
  TTD ID: DKFP51

References

• [1] A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II. Mol Ther. 2021 Feb 3;29(2):671-679.